Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery.
Ansley DM, Raedschelders K, Chen DD, Choi PT. Ansley DM, et al. Contemp Clin Trials. 2009 Jul;30(4):380-5. doi: 10.1016/j.cct.2009.03.004. Epub 2009 Mar 29. Contemp Clin Trials. 2009. PMID: 19336262 Clinical Trial.
40 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page